Global Biopharmaceutical Market to Reach US$ 643.9 Billion by 2032, Impelled by Rising Prevalence of Chronic Diseases.

May 19, 2022 | Healthcare

According to the latest report by IMARC Group, titled "Biopharmaceutical Market Report by Indication (Autoimmune Diseases, Oncology, Metabolic Disorders, and Others), Class (Recombinant Proteins, Monoclonal Antibodies, Purified Proteins), and Region 2024-2032" the global biopharmaceutical market reached a value of US$ 300.5 Billion in 2023. Biopharmaceutical refers to a pharmaceutical product that is generally manufactured using various biological sources, including living cells or organisms. Primarily developed in industrial and academic laboratories, it aids in the treatment of several diseases, such as cancers and metabolic disorders. It is widely preferred by healthcare professionals across the globe since it causes minimum side effects to the body, targets only specific molecules, and exhibits high specificity to address various untreatable medical conditions. The demand for biopharmaceutical products is continuously increasing due to the easy accessibility to quality healthcare facilities.

Global Biopharmaceutical Market Trends:

The global market is primarily driven by the rising prevalence of chronic diseases among individuals. This is supported by the sedentary lifestyle led by the masses and the growing geriatric population. Moreover, continuous improvements in biotechnology, along with the increasing investments and funding by numerous public and private firms to upgrade the overall infrastructure, are creating a positive market outlook. Additionally, continual technological advancements, such as the widespread adoption of 3D printing and gene writing as well as the integration of artificial intelligence with supercomputers, are creating lucrative growth opportunities for key players in the biopharmaceutical market. In line with this, extensive research and development (R&D) activities conducted in genetic research are favorably impacting the market growth worldwide. Other factors, including the increasing number of research laboratories and clinical trials across multiple countries and supportive regulations implemented by various governments, are also influencing the growth of the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 643.9 Billion by 2032, exhibiting a CAGR of 8.6% during 2024-2032.

Market Summary:

  • Based on the indication, the market has been classified into autoimmune diseases, oncology, metabolic disorders and others. 
  • On the basis of the class, the market has been segregated into recombinant proteins, monoclonal antibodies and purified proteins.
  • Based on the region, the market has been divided into North America (the United States and Canada), Latin America (Mexico, Brazil, and Argentina), Europe (Germany, France, Italy, Spain, the United Kingdom, Russia, and Turkey ) and Asia Pacific (Japan, China, Australia, South Korea, India, and Indonesia).
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of these players include AbbVie Inc., Amgen Inc, Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novo Nordisk A/S, Pfizer Inc. and Sanofi S.A.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Indications Covered Autoimmune Diseases, Oncology, Metabolic Disorders, Others
Classes Covered Recombinant Proteins, Monoclonal Antibodies, Purified Proteins
Regions Covered North America, Latin America, Europe, Asia Pacific
Countries Covered United States, Canada, Mexico, Brazil, Argentina, Germany, France, Italy, Spain, United Kingdom, Russia, Turkey, Japan, China, Australia, South Korea, India, Indonesia
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Biopharmaceutical Market to Reach US$ 643.9 Billion by 2032, Impelled by Rising Prevalence of Chronic Diseases.
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More